Table 1.
3F6-hIgG1CHO | |||||||
Ligand | Ka, M−1 | WT | Gal | deSia | G2F | ||
SpAKKAA | 1010 | 2.54 ± 0.46 | 2.74 ± 0.23 | 2.85 ± 0.33 | 1.93 ± 0.13 | ||
Human C1q | 106 | 4.91 ± 0.24 | 21.7 ± 1.71 | 5.50 ± 0.15 | 51.1 ± 6.57 | ||
Mouse C1q | 106 | 8.87 ± 0.59 | ND | ND | ND | ||
3F6-hIgG1HEK | |||||||
Ligand | Ka (M−1) | WT | deGal | deSia | G0F | G1F | G2F |
SpAKKAA | 1010 | 2.44 ± 0.52 | 2.86 ± 0.33 | 2.90 ± 0.32 | 2.34 ± 0.13 | 2.24 ± 0.16 | 1.93 ± 0.16 |
Human C1q | 106 | 18.7 ± 4.0 | 4.0 ± 0.70 | 33.7 ± 3.74 | 6.94 ± 0.39 | 38.3 ± 3.58 | 55.0 ± 6.03 |
Mouse C1q | 106 | 60.8 ± 7.44 | ND | ND | ND | ND | ND |
WT, wild-type; Gal, galactosylated; deSia, desialylated; ND, not determined; deGal, degalactosylated.